Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ETON | AMGN | GILD | CELG | VRTX |
| Company | Eton Pharmaceutcials Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.15 | 265.72 | 65.50 | 108.01 | 393.52 |
| High | 3.56 | 271.68 | 66.35 | 108.59 | 399.68 |
| Low | 3.15 | 265.72 | 64.63 | 107.27 | 393.49 |
| Last | 3.27 | 269.71 | 65.67 | 108.24 | 399.10 |
| Change | +0.15 | +0.33 | +0.40 | +0.11 | +1.40 |
| % Change | +4.81% | +0.12% | +0.61% | +0.10% | +0.35% |
| Volume | 32,855 | 514,268 | 6,094,055 | 191,230,496 | 214,972 |
| 20-Day Average Volume | 51,994 | 2,059,038 | 6,740,627 | 16,188,930 | 919,868 |
| Previous Close | 3.12 | 269.38 | 65.27 | 108.13 | 397.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.38 | 269.99 | 68.31 | 108.17 | 401.36 |
| 20-Day Raw Stochastic | 34.58% | 40.12% | 13.04% | 63.25% | 26.48% |
| 20-Day Relative Strength | 43.76% | 45.49% | 31.11% | 64.69% | 43.94% |
| Weighted Alpha | -24.47 | +9.46 | -22.95 | +46.30 | +15.41 |
| Today's Opinion | 72% Sell | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 88% Sell | 72% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 24% Sell | 40% Buy | 88% Sell | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.58% since 04/19/24 | +0.40% since 04/19/24 | -1.51% since 04/19/24 | -1.97% since 11/13/19 | +1.21% since 04/19/24 |
| Low | 3.11 on 04/25/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 107.27 on 11/20/19 | 393.00 on 04/25/24 |
| High | 3.56 on 04/26/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -10.76% since 03/26/24 | -4.18% since 03/26/24 | -9.20% since 03/26/24 | +5.14% since 10/18/19 | -4.63% since 03/26/24 |
| Low | 3.03 on 04/17/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 4.10 on 04/02/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -25.44% since 01/26/24 | -13.40% since 01/26/24 | -17.32% since 01/26/24 | +13.63% since 08/20/19 | -7.23% since 01/26/24 |
| Low | 3.03 on 04/17/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 4.75 on 02/06/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -11.46% since 10/26/23 | +0.11% since 10/26/23 | -16.24% since 10/26/23 | +14.14% since 05/20/19 | +10.46% since 10/26/23 |
| Low | 3.03 on 04/17/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 5.11 on 01/08/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 80,147 | 144,488,960 | 81,266,176 | 77,035,920 | 102,789,152 |
| Shares Outstanding, K | 25,688 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 31,640,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -940,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 7,310,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -2,260,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 1.17 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 03/14/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 10.99 | 29.82 |